David Westenberg Analyst Performance

Sr. Research Analyst at Piper Sandler

David Westenberg is a stock analyst at Piper Sandler focused in the medical sector, covering 21 publicly traded companies. Over the past year, David Westenberg has issued 43 stock ratings, including buy and hold recommendations. While full access to David Westenberg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Westenberg's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 49 Last 7 Years
Buy Recommendations: 58.33% 28 Buy Ratings
Companies Covered: 21 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	58.3%	28 ratings
Hold	41.7%	20 ratings
Sell	0.0%	0 ratings

Out of 48 total stock ratings issued by David Westenberg at Piper Sandler, the majority (58.3%) have been Buy recommendations, followed by 41.7% Hold.

Best & Worst Calls

Best Call
0000.0%
TRUP
Nov 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
PETX
Mar 2018
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	81.0% of companies on NASDAQ	17 companies
NYSE	19.0% of companies on NYSE	4 companies

David Westenberg, an analyst at Piper Sandler, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 20 companies	95.2%
	Finance 1 company	4.8%

David Westenberg of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Finance companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 7 companies	33.3%
MEDICAL INFO SYS 3 companies	14.3%
MEDICAL SERVICES 3 companies	14.3%
MED INSTRUMENTS 2 companies	9.5%
MED - OUTP/HM CRE 2 companies	9.5%
MED - DRUGS 1 company	4.8%
MED PRODUCTS 1 company	4.8%
INS - ACC & HLTH 1 company	4.8%
PHARMACEUTICAL PREPARATIONS 1 company	4.8%

About David Westenberg

David Westenberg is senior research analyst and managing director at Piper Sandler covering animal health and genomics tools and labs. Prior to joining Piper Sandler in 2021, Westenberg was a senior analyst at Guggenheim Securities, covering diagnostics labs, genomic instruments and animal health. Prior to joining Guggenheim, he was a senior analyst at CL King, leading the coverage of diagnostics and animal health. Westenberg is a CFA Charterholder, and was a StarMine runner-up for stock picking in medical equipment in 2018. He has a master’s in finance from Bocconi University in Milan and a Bachelor of Science in business administration from San Francisco State.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
TXG 10x Genomics	9/11/2025	Initiated Coverage	$12.59	$15.00	Neutral
WGS GeneDx	9/11/2025	Boost Price Target	$129.25	$140.00	Overweight
ZTS Zoetis	8/11/2025	Boost Price Target	$147.34	$215.00	Overweight
IDXX IDEXX Laboratories	8/11/2025	Reiterated Rating	$658.06	$700.00	Neutral
NTRA Natera	8/11/2025	Reiterated Rating	$151.95	$220.00	Overweight
ELAN Elanco Animal Health	8/11/2025	Boost Price Target	$16.61	$18.00	Neutral
EXAS Exact Sciences	8/11/2025	Lower Price Target	$40.99	$60.00	Overweight
PACB Pacific Biosciences of California	8/11/2025	Boost Price Target	$1.35	$1.50	Neutral
ADPT Adaptive Biotechnologies	8/6/2025	Boost Price Target	$11.34	$15.00	Overweight
NEO NeoGenomics	8/4/2025	Set Price Target	$5.45	$11.00	Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
WGS GeneDx	8/4/2025	Set Price Target	$105.18	$120.00	Overweight
FLGT Fulgent Genetics	8/4/2025	Set Price Target	$18.18	$21.00	Neutral
WGS GeneDx	7/9/2025	Initiated Coverage	$85.22	$110.00	Overweight
TEM Tempus AI	5/15/2025	Boost Price Target	$63.76	$70.00	Neutral
PACB Pacific Biosciences of California	5/15/2025	Lower Price Target	$1.06	$1.25	Neutral
NTRA Natera	5/15/2025	Boost Price Target	$149.42	$210.00	Overweight
ILMN Illumina	5/15/2025	Lower Price Target	$80.65	$185.00	Overweight
ZTS Zoetis	5/12/2025	Boost Price Target	$162.37	$210.00	Overweight
NEO NeoGenomics	5/6/2025	Set Price Target	$7.84	$12.00	Overweight
LH Labcorp	5/6/2025	Reiterated Rating	$245.96	$280.00	Neutral
GH Guardant Health	5/6/2025	Reiterated Rating	$43.68	$60.00	Overweight
FLGT Fulgent Genetics	5/6/2025	Reiterated Rating	$18.96	$23.00	Neutral
ADPT Adaptive Biotechnologies	5/6/2025	Reiterated Rating	$10.03	$13.00	Overweight
DGX Quest Diagnostics	4/28/2025	Boost Price Target	$175.47	$200.00	Neutral
NEOG Neogen	4/22/2025	Lower Price Target	$4.82	$5.00	Neutral
NEOG Neogen	4/14/2025	Lower Price Target	$5.58	$6.50	Neutral
AKYA Akoya Biosciences	4/14/2025	Lower Price Target	$1.23	$1.65	Neutral
ELAN Elanco Animal Health	3/6/2025	Lower Price Target	$10.77	$12.00	Neutral
CTKB Cytek Biosciences	3/4/2025	Lower Price Target	$4.30	$8.00	Overweight
TEM Tempus AI	3/4/2025	Lower Price Target	$50.13	$55.00	Neutral
NTRA Natera	3/4/2025	Boost Price Target	$137.97	$205.00	Overweight
FLGT Fulgent Genetics	3/4/2025	Lower Price Target	$14.98	$16.00	Neutral
ZTS Zoetis	2/27/2025	Boost Price Target	$164.99	$205.00	Overweight
NEO NeoGenomics	2/26/2025	Lower Price Target	$10.64	$18.00	Overweight
GH Guardant Health	2/26/2025	Boost Price Target	$43.13	$50.00	Overweight
EXAS Exact Sciences	2/26/2025	Lower Price Target	$48.71	$70.00	Overweight
PACB Pacific Biosciences of California	2/20/2025	Reiterated Rating	$1.63	$2.00	Neutral
ADPT Adaptive Biotechnologies	2/20/2025	Reiterated Rating	$8.48	$11.00	Overweight
ILMN Illumina	2/10/2025	Boost Price Target	$103.65	$190.00	Overweight
ZTS Zoetis	2/10/2025	Lower Price Target	$171.12	$200.00	Overweight

IDXX IDEXX Laboratories	2/10/2025	Boost Price Target	$463.58	$510.00	Neutral
DGX Quest Diagnostics	2/3/2025	Reiterated Rating	$161.06	$180.00	Neutral
NEOG Neogen	1/21/2025	Reiterated Rating	$11.78	$13.00	Neutral

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.